Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dental plaque bacteria represent the diverse microbial community forming a biofilm on tooth surfaces. These bacteria metabolize dietary carbohydrates, producing acids that demineralize enamel, leading to caries. Specific species like Streptococcus mutans and Porphyromonas gingivalis are key pathogens. Effective management involves disrupting the biofilm through hygiene practices and antimicrobial agents, while novel therapies target specific pathogens without harming beneficial bacteria.
Antibiotics and antiseptics disrupt bacterial cell walls or metabolic processes. Fluoride strengthens enamel and inhibits bacterial enzymes. Enzyme inhibitors target biofilm formation.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dental Plaque Bacteria.